Cross-species liver cell growth could represent a solution to transplant shortage

FHS
May 9, 2024
3:24 am

Liver disease, due to viral infections, alcohol abuse, obesity, or cancer, accounts for 1 in every 25 deaths worldwide.

WHO director general: A breakthrough global agreement on combatting antimicrobial resistance

At the U.N. General Assembly in New York on Thursday, all countries approved a major new political declaration to radically scale up efforts to combat

September 27, 2024

Long-Acting Schizophrenia Tx Shows Long-Term Safety With Limited Relapses

NASHVILLE, Tenn. — Every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) for schizophrenia was effective and safe up to 3 years, researchers reported

September 12, 2023

A young girl’s custom gene therapy hints at a framework for tailored rare disease treatments

When Timothy Yu developed milasen, a custom drug for a young girl named Mila with Batten disease, he ignited a spark in the field of

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.